RecruitingPhase 2NCT05499637

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Studying Sarcoidosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: John O. Prior
Principal Investigator: John O Prior, MD, PhD
University of Lausanne Hospitals
Intervention: [68Ga]Ga-PentixaFor PET/CT(drug)
Enrollment: 69 target
Eligibility: 18 years · All sexes
Timeline: 2023 – 2026

Study locations (1)

Centre Hospitalier Universitaire Vaudois, Lausanne, Canton of Vaud, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05499637 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT07498842
Corticosteroid Tapering in Sarcoidosis
Royal Brompton & Harefield NHS Foundation Trust
RECRUITINGNANCT07073963
Virtual Patient Groups for Sarcoidosis Associated Fatigue
The Cleveland Clinic
RECRUITINGPHASE2NCT07159074
Repurposing Tilmanocept for Cardiac Sarcoidosis
Duke University
RECRUITINGPHASE2NCT06978725
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
Priovant Therapeutics, Inc.
RECRUITINGNANCT05954507
Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis
Assistance Publique - Hôpitaux de Paris
RECRUITINGPHASE2NCT06660732
Rilonacept in Subjects With Cardiac Sarcoidosis
Mayo Clinic
RECRUITINGNANCT07384897
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
Université Catholique de Louvain
RECRUITINGNCT06510894
Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression
University of Pennsylvania

See all trials for Sarcoidosis →

← Back to all trials